MedTrace Logo

Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma

NCT03601689 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2018-07-26

No results posted yet for this study

Summary

Many data suggest that patients with low rectal adenocarcinoma who achieved ypT0N0 status have improved survival and disease-free survival (DFS) compared to all other stages however only few data are available regarding the specific prognosis factors of this subgroup. This retrospective multicentric study aimed to predict the prognosis of patients with complete pathological response after neoadjuvant treatment.

Conditions

  • Rectal Neoplasms

Interventions

PROCEDURE

rectal resection

total mesorectal excision

Sponsors & Collaborators

  • Moroccan Society of Surgery

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-01
Primary Completion
2013-12-31
Completion
2016-03-31

Countries

  • Algeria
  • Morocco

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03601689 on ClinicalTrials.gov